Metabolic syndrome and risk of pulmonary involvement

Respiratory Medicine

Volumn 104, Issue 1, 2010, Pages 47-51

  Rogliani, Paola ^a   Curradi, Giacomo ^a   Mura, Marco ^a   Lauro, Davide ^a   Federici, Massimo ^a   Galli, Angelica ^a   Saltini, Cesare ^a   Cazzola, Mario ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Airflow limitation; HDL C; Metabolic syndrome; Pulmonary involvement

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SPIROMETRY; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SPIROMETRY;

EID: 73749085552     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.08.009     Document Type: Article

References (28)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, And Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
2. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
3. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
4. Wouters E.F. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 26-33
5. Agusti A., and Soriano J.B. COPD as a systemic disease. COPD 5 (2008) 133-138
6. Watz H., Waschki B., Kirsten A., et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest (2009) 0309-0393 10.1378/chest
7. Poulain M., Doucet M., Major G.C., et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 174 (2006) 1293-1299
8. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
9. Matthews D.R., Hosker J.P., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
10. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 144 (1991) 1202-1218
11. Dykstra B.J., Scanlon P.D., Kester M.M., Beck K.C., and Enright P.L. Lung volumes in 4,774 patients with obstructive lung disease. Chest 115 (1999) 68-74
12. Fimognari F.L., Pasqualetti P., Moro L., et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 62 (2007) 760-765
13. Lin W.Y., Yao C.A., Wang H.C., and Huang K.C. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity 14 (2006) 1654-1656
14. Nakajima K., Kubouchi Y., Muneyuki T., Ebata M., Eguchi S., and Munakata H. Possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 134 (2008) 712-718
15. Stanescu D. Small airways obstruction syndrome. Chest 116 (1999) 231-233
16. Lange P., Parner J., Schnohr P., and Jensen G. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 20 (2002) 1406-1412
17. Shaw R.J., Djukanovic R., Tashkin D.P., Millar A.B., du Bois R.M., and Orr P.A. The role of small airways in lung disease. Respir Med 96 (2002) 67-80
18. Guazzi M., Brambilla R., Pontone G., Agostoni P., and Guazzi M.D. Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure. Am J Cardiol 89 (2002) 191-197
19. Zerah F., Harf A., Perlemuter L., Lorino H., Lorino A.M., and Atlan G. Effects of obesity on respiratory resistance. Chest 103 (1993) 1470-1476
20. Kannel W.B., Cupples L.A., Ramaswami R., Stokes III J., Kreger B.E., and Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 44 (1991) 183-190
21. Chinn D.J., Cotes J.E., and Reed J.W. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 51 (1996) 699-704
22. Lazarus R., Gore C.J., Booth M., and Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 68 (1998) 35-41
23. Carey I.M., Cook D.G., and Strachan D.P. The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord 23 (1999) 979-985
24. Canoy D., Luben R., Welch A., et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 159 (2004) 1140-1149
25. Lazarus R., Sparrow D., and Weiss S.T. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 12 (1998) 641-645
26. Lawlor D.A., Ebrahim S., and Smith G.D. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Womens Heart And Health Study. Diabetologia 47 (2004) 195-203
27. Ballantyne C., Arroll B., and Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J 26 (2005) 2224-2231
28. Sin D.D., Wu L., and Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127 (2005) 1952-1959